Mohamed Sheta is a Lecturer of Clinical Oncology and Nuclear Medicine and Consultant of Clinical Oncology at Nile Hospital for Medical Insurance, Cairo in Tanta University. He has published his papers in reputed journals.
Clinical Oncology, Cancer Therapy, Chemotherapy
Dr Helieh S. Oz has DVM, and MS (U. IL); PhD (U. MN) and clinical translational research certificate (U. KY Med Center). Dr Oz is an active member of American Association of Gastroenterology (AGA) and AGA Fellow (AGAF). Dr Oz is Microbiologist scientist with expertise in infectious and inflammatory diseases, drug discoveries, pathogenesis, innate and mucosal Immunity, molecular biology, and micronutrient. Dr Oz has over 90 publications in areas of chronic inflammatory disorders (e.g. pancreatitis, hepatitis, colitis), microbial and infectious diseases (e.g. Toxoplasmosis, Trypanosomasis, Babesiosis, Coccidiosis, Pneumocystis pneumonia). She has served as Lead editor for special issues including Gut Inflammatory, Infectious diseases and Nutrition 2017 (Mediators of Inflammation); Nutrients, Infectious and Inflammatory Diseases 2017 (Nutrients); Gastrointestinal Inflammation and Repair: Role of Microbiome, Infection, Nutrition 2016 (Gastroenterology Research Practice), and co-editor for Parasitic infections in pediatric clinical practice 2017 (J Pediatric Infectious Disease), Chagas Disease, Intech Open Science 2017 and member of different advisory committees.
Infection, Immunology of infectious disease, Innate Immunity, Microbiology
Octavian Bucur is working as an Instructor in the Departments of Pathology and Medicine at the Harvard Medical School, BIDMC, in Boston, MA, focusing on the development and application of new experimental and computational technologies with significant impact in molecular, diagnostic pathology and personalized medicine. He is also a member of the Ludwig Cancer Center at Harvard and Broad Institute of MIT and Harvard. In collaboration with Dr. Edward Boyden’s laboratory at MIT, he has developed a pathology-optimized physical tissue expansion method called Expansion Pathology that enables ~100 times expansion in volume of any type of clinical specimen and visualization of 70-80 nm structures with conventional optical microscopes (currently limited to ~250 nm resolution). Expansion Pathology has the potential of replacing electron microscopy in diagnosis and investigation of certain pathologies and nanometer structures
Obstetrics & Gynecology of Nursing.
Cancer, Obstetrics and Gynecology
Bioorganic Chemistry, Tumor Studies and Molecular Medicine
Reproductive Medicine, clinical sexology, Breast Pathology, Maternity and Neonatology
Dr. Priyanka Debta has completed her M.D.S. in Oral Pathology and Microbiology (2006-2009) from Deemed University S.P.D.C., Sawangi, Maharashtra, INDIA. She has done research in the field of immunological cells infiltration in carcinoma and in odontogenic cysts & in forensic odontology. She has participated in various national and international conferences and presented papers and posters. Presently she is working in I.D.S., SOA UNIVERSITY, BBSR, Odisha, India. Her various studies and reports have been published in the reputed national/international journals. She is a dedicated, resourceful and innovative instructor for her students that helps in intellectual growth by creating an atmosphere of mutual respect and open communication.
Her broad area of interest in evaluation of immunological cells infiltration in oral oncology and various odontogenic cyst.
Dr Pegah Varamini is an early career researcher, lecturer and group leader in Cancer Theme within the Faculty of Pharmacy. She is the leader of Breast Cancer Targeting-Drug Delivery Group. Dr Varamini was awarded the prestigious National Breast Cancer Foundation (NBCF) fellowship and grant in Jan 2016. She completed her Doctorate degree in Pharmacy (PharmD) at Shiraz University of Medical Sciences, Iran, in May 2005. In 2009 she was granted the competitive Australian international scholarships, UQRS/IPRS, to pursue full-time PhD studies at The University of Queensland. She was awarded her PhD degree in Medicinal Chemistry and Pharmacology in December 2012. She won awards and prizes during her PhD studies, e.g. 2012 Dean’s Award for Research Higher Degree Excellence highlighting her successful approach in performing a high-quality research. Dr Varamini lead a hormone-based peptide/vaccine delivery ARC-funded research project at The University of Queensland until December 2015 as a postdoctoral research fellow prior to being granted the NBCF fellowship and joining the University of Sydney in January 2016. She has published 24 peer-reviewed articles across 11 different fields (SciVal, 3/11/2016) that confirm her multidisciplinary research. Dr Varamini’s work was selected by the Australian Academy of Science in August 2016, resulting in her personal presentation at the inaugural Falling Walls Lab in Canberra (a gathering of 25 selected Australian and New Zealand researchers, entrepreneurs, engineers and innovators). Furthermore, NBCF has found her research both innovative and promising and the result was that she was the featured researcher in 2016 in multiple events and programs. Also her work is being published in NBCF 2016 annual report.
Breast Cancer Targeting-Drug Delivery